ELA vs JNJ · P/E 21, rev $155.2M vs P/E 17, rev $49.37B
Envela Corp (ELA) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Envela Corp (ELA) is a luxury goods company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported ELA revenue for 2026-06-30 was $155.2M. Net income was $13.0M. Revenue was up 57.7% from 2026-03-31 to 2026-06-30. ELA currently screens at market cap $158.1M and trailing P/E 21.0.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
ELA currently screens at market cap $158.1M and trailing P/E 21.0. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the ELA and JNJ stock pages for the full models.
Not investment advice.